Story thread · 14 reports / 12 sources
STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more
statnews.com · 21h
How the coverage leans
Across 12 sources · syndicated copies counted once
AstraZeneca disclosed that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors
First report: New drug for advanced breast cancer guided by blood test approved by FDA — wxyz.com, 3d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.